Project 0933
$6.9MFY2027 request ▼ 10%Medical/Dental Equipment Dev
FY2025 actual$8.1M
FY2026 enacted$7.6M
FY2027 request$6.9M
Product DevelopmentTest and EvaluationManagement Services
FY2027 Request
$6.9M
▼ 40% vs FY2026
FY2026 Enacted
$11.5M
▲ 42% vs FY2025
FY2025 Actual
$8.1M
Prior year
Roll-up of 2 projects. Projects are the summable leaves — the PE total is their sum, never added to it.
For fiscal year 2027, the U.S. Navy is requesting $6.9M for Medical Development under RDT&E program element 0604771N, down 40% from FY2026.
Funding trajectory
Funding profile, FY2025–FY2031
Prior years are actuals, the budget year is the request, and the outyears are the FYDP plan. Estimate types are colored and never summed into one figure.
Actual Enacted Request Outyear (FYDP)
| Fiscal Year | Estimate Type | Amount ($M) |
|---|---|---|
| FY2025 | Actual | 8.1 |
| FY2026 | Enacted | 11.5 |
| FY2027 | Request | 6.9 |
| FY2028 | Outyear | 7.1 |
| FY2029 | Outyear | 7.2 |
| FY2030 | Outyear | 7.3 |
| FY2031 | Outyear | 7.4 |
Where it sits
Acquisition lifecycle
This program is funded in RDT&E Budget Activity 5 — System Development & Demonstration.
Complete
Research
BA 1–2
Complete
Advanced Technology
BA 3
Complete
Prototyping
BA 4
Current
Development & Fielding
BA 5–7
Inside the program element
2 projects roll up into PE 0604771N
Projects are the summable leaves — the PE total is their sum, never added to it. Program elements and projects carry the full five-year plan; activities stop at the budget year. This PE moves -40% overall, which can hide much larger swings below.
Project 9999
$0.0MFY2027 request ▼ 100%Congressional Adds
FY2025 actual$0.0M
FY2026 enacted$3.9M
FY2027 request$0.0M
Product Development
Congressional action
Congressional marks
Committee marks on the FY2027 request. Adds and cuts are reconciled in conference before they become law.
RequestPresident's Budget
$6.9M
House NDAA (HASC)HASC
$6.9M full · +$0
Senate NDAA (SASC)SASC
$6.9M full · +$0
House Approps (HAC-D)HAC_D
$6.9M full · +$0
unresolved as of 2026-07-27. These are FY2027 authorization marks (NDAA); appropriations and the conference agreement may differ.
Who's building it
Where the FY2027 request goes
Performers named in the R-3 exhibit, resolved into industry, government-lab, and unspecified shares. Budget-justification contract funding, not obligations.
| Where FY2027 funding flows | Share | $M |
|---|---|---|
| Government labs & warfare centers | 11% | 0.8 |
| Other / unspecified | 89% | 6.1 |
| FY2027 request | 100% | 6.9 |
Program detail
Mission & acquisition strategy
The purpose of this program is to develop biomedical equipment and related techniques to reduce morbidity; to enhance the logistic feasibility of modern medical care for combat casualties; to sustain casualties for evacuation to fixed medical facilities for definitive care; and to ensure that personnel are medically qualified for military duty. Each work unit undertaken in this project has a military requirement. Efforts are justified based upon military payoff and cost benefit. There is a strong potential for dual use, technology transfer, and biotechnology firms/industry participation in the projects.
The acquisition strategy for product lines and products in the Medical Development Program is designed and implemented consistently with the purpose of the particular product and with the nature and size of the investment. The major Product Areas in the Medical Development Program are: 1) Equipment, 2) Pharmaceuticals/Biologics, and 3) Operational Knowledge/Concepts. The primary Program Areas of Interest are: 1) Optimize health, performance, and resilience of the ready and forward operating forces; 2) Enhance medical logistics; 3) Reduce mortality and morbidity from battlefield and mission-related injuries in support of Navy Health Services Support in Terrestrial, Maritime Surface, Submarine, and Aviation Operations and USMC in Expeditionary…
Project 0933, 9999 — Medical/Dental Equipment Dev
- Product Development
- Test and Evaluation
- Management Services
Ask Hitch
Ask this program element
Answers are generated from the figures on this page — the FY2027 justification exhibits and the marks tracked above — and nothing else is consulted. Confirm any figure against the cited exhibit before you use it externally.
H
Questions this page can answer
How does the FY2027 request compare with FY2026, and what does the five-year plan show?What did the FY2027 NDAA committees do to this request?Which project inside PE 0604771N is growing fastest, and which is shrinking?How is the FY2027 request split between industry and government performers?
This page carries the budget justification and the NDAA marks — nothing else. For what a contractor has actually been obligated, the ledger is at hitchintel.com/vendors; for live solicitations, hitchintel.com/opportunities. Both are member surfaces.
Provenance
Cite this page
Sources
FY2027 Department of the Navy RDT&E Budget Justification · Exhibits R-2 / R-3 · PE 0604771N (President's Budget PB2027) — and FY2027 NDAA committee marks, as tracked 2026-07-27.
Suggested citation
HitchAI, "Medical Development (PE 0604771N)," federal budget intelligence, PB2027 vintage. hitchintel.com/programs/0604771N
Machine access
Markdown twin
/programs/0604771N.md · MCP mcp.hitchintel.com → budget_get_program_element, budget_get_cong_marksFY2027 Request
$6.9M
▼ 9.6% vs FY2026
FY2026 Enacted
$7.6M
▼ 5.9% vs FY2025
FY2025 Actual
$8.1M
Prior year
Medical/Dental Equipment Dev — one RDT&E project inside PE 0604771N. Congressional marks are recorded on the program element, not on a project.
Project 0933 — Medical/Dental Equipment Dev — requests $6.9M in FY2027, 100% of the $6.9M requested for program element 0604771N. Year over year it falls 9.6% against FY2026.
Funding trajectory
Project 0933 funding, FY2025–FY2031
Prior years are actuals, the budget year is the request, and the outyears are the FYDP plan. Estimate types are colored and never summed into one figure. Projects carry the full five-year plan; the activities inside them stop at the budget year.
Actual Enacted Request Outyear (FYDP)
| Fiscal Year | Estimate Type | Amount ($M) |
|---|---|---|
| FY2025 | Actual | 8.1 |
| FY2026 | Enacted | 7.6 |
| FY2027 | Request | 6.9 |
| FY2028 | Outyear | 7.1 |
| FY2029 | Outyear | 7.2 |
| FY2030 | Outyear | 7.3 |
| FY2031 | Outyear | 7.4 |
Inside the project
2 accomplishments / planned programs
The R-2A exhibit. Activities carry the prior, current and budget year only — no five-year plan — and they are descriptive: coverage is partial and they do not always add back to the project, so count them, never total them.
Medical/Dental Equipment Development▼ 10%
FY2025 actual$7.1M
FY2026 enacted$6.8M
FY2027 request$6.1M
FY2027 planned work -Continue evaluation of physiological monitoring sensor system in relevant military environments. -Continue Human Performance: Neurocognitive Tool Development and Test & Evaluation. -Continue Test & Evaluation Autonomous Aerial Technology for Distributed Logistics of Critical Medical Supplies.
FY2026 to FY2027 change Decrease (-$0.675M) from FY 2026 to FY 2027 reflects slight rephase to the program.
FY2026 plans — current year -Complete cabin-pressure/decompression sickness (DCS) test and evaluation capability. -Continue evaluation of physiological monitoring sensor system in relevant military environments. -Continue Human Performance: Neurocognitive Tool Development and Test & Evaluation. -Complete Human Performance: Antiemetic. -Continue Test & Evaluation Autonomous Aerial Technology for Distributed Logistics of Critical Medical Supplies.
Expeditionary Medical Family of Systems▼ 6%
FY2025 actual$1.0M
FY2026 enacted$0.8M
FY2027 request$0.8M
FY2027 planned work Expeditionary Medical (ExMed) Family of Systems (FoS) will continue to perform developmental and operational testing and suitability evaluation for the ExMed FoS to include Certified Diagnostic Mobile Laboratory (CDML), Expeditionary Resuscitative Surgical Systems (ERSS), and En Route Care Systems (ERCS). ExMed FoS will continue product development of Expeditionary Medical Unit (EMU) to provide Role 2 care Ashore and Afloat.
FY2026 to FY2027 change No significant change.
FY2026 plans — current year Expeditionary Medical (ExMed) Family of Systems (FoS) will continue to perform developmental and operational testing and suitability evaluation for the ExMed FoS to include Certified Diagnostic Mobile Laboratory (CDML), Expeditionary Resuscitative Surgical Systems (ERSS), and En Route Care Systems (ERCS). ExMed FoS will continue product development of Expeditionary Medical Unit (EMU) to provide Role 2 care Ashore and Afloat.
Project detail
What project 0933 buys
The purpose of this program is to develop biomedical equipment and related techniques to reduce morbidity; to enhance the logistic feasibility of modern medical care for combat casualties; to sustain casualties for evacuation to fixed medical facilities for definitive care; and to ensure that personnel are medically qualified for military duty. Each work unit undertaken in this project has a military requirement. Efforts are justified based upon military payoff and cost benefit. There is a strong potential for dual use, technology transfer, and biotechnology firms/industry participation in the projects. The purpose of this program is also to develop, test, and evaluate expeditionary medical systems and equipment to save warfighter lives, facilitate movement of patients up the roles of care, and return warfighters to the fight, especially in the Distributed Maritime environment. Each work unit undertaken in this program has a military requirement. Efforts are justified based upon military payoff and cost benefit. There is a strong potential for dual use, technology transfer, and biotechnology firms/industry participation in the projects.
R-3 lines of work
- Product Development
- Test and Evaluation
- Management Services
FY2027 Request
$0.0M
▼ 100% vs FY2026
FY2026 Enacted
$3.9M
No FY2025 funding
FY2025 Actual
$0.0M
Prior year
Congressional Adds — one RDT&E project inside PE 0604771N. Congressional marks are recorded on the program element, not on a project.
Project 9999 — Congressional Adds — requests $0.0M in FY2027, 0.0% of the $6.9M requested for program element 0604771N. Year over year it falls 100% against FY2026.
Funding trajectory
Project 9999 funding, FY2025–FY2031
Prior years are actuals, the budget year is the request, and the outyears are the FYDP plan. Estimate types are colored and never summed into one figure. Projects carry the full five-year plan; the activities inside them stop at the budget year.
Actual Enacted Request Outyear (FYDP)
| Fiscal Year | Estimate Type | Amount ($M) |
|---|---|---|
| FY2025 | Actual | 0.0 |
| FY2026 | Enacted | 3.9 |
| FY2027 | Request | 0.0 |
| FY2028 | Outyear | 0.0 |
| FY2029 | Outyear | 0.0 |
| FY2030 | Outyear | 0.0 |
| FY2031 | Outyear | 0.0 |
Project detail
What project 9999 buys
The purpose of this program is to develop, test, and evaluate Expeditionary On-Demand Saline Solutions to save warfighter lives, facilitate movement of patients up the roles of care, and return warfighters to the fight, especially in the Distributed Maritime environment.
R-3 lines of work
- Product Development